Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018482638> ?p ?o ?g. }
- W2018482638 endingPage "1158" @default.
- W2018482638 startingPage "1153" @default.
- W2018482638 abstract "The use of estrogen by postmenopausal women decreases plasma low-density lipoprotein (LDL) cholesterol levels. To determine whether LDL subclass profiles influence this response, we studied 31 healthy postmenopausal women who were administered two doses (0.625 and 1.25 mg/d) of conjugated equine estrogen in a placebo-controlled double-blind crossover study. Lipid-stained gradient gels were used to categorize LDL subclass patterns. All women were classified as LDL subclass pattern A (predominant LDL peak ≥260 Å). Within the pattern A classification, there were 12 women during placebo treatment with LDL subclass I pattern (predominant LDL peak >271 Å) and 19 women with LDL subclass II pattern (predominant LDL peak ≤ 271 and ≥ 260 Å). Postmenopausal women with LDL subclass I on placebo treatment had significantly lower LDL cholesterol levels compared with women having LDL subclass II (126 ± 28 v 147 ± 23 mg/dL, P < .03). Postmenopausal women with LDL subclass I also had significantly (P < .05) lower very-low-density lipoprotein (VLDL) cholesterol, VLDL triglyceride, and VLDL apo B levels and significantly higher (P < .05) high-density lipoprotein 2 (HDL2) cholesterol, HDL3 cholesterol, and HDL2 apo A-I levels. Estrogen replacement significantly (P < .05) decreased LDL cholesterol levels and increased VLDL and LDL triglyceride, HDL2 and HDL3 cholesterol and apo A-I, and HDL2 apo A-II levels to a similar extent in postmenopausal women with LDL I or II subclass patterns. Estrogen replacement at either dose in postmenopausal women with the LDL I subclass pattern decreased LDL I relative peak area and LDL II peak particle diameter from 55% ± 1.7% to 39% ± 2.3% (mean ± SEM, P < .001) and from 269 ± 0.5 to 267 ± 0.7 Å (mean ± SEM, P < .001), respectively. In postmenopausal women with the LDL II subclass pattern, no significant change in LDL subclass distribution or peak diameter was noted. The prevalence of pattern B (predominant LDL peak <260 Å) and the mean proportion of LDL subclass III particles (<260 Å, 12%) were unaffected by estrogen treatment. In summary, estrogen replacement therapy decreased the proportion of large LDL I particles and increased the proportion of intermediate-size LDL II particles in healthy postmenopausal women with a predominance of large LDL particles at baseline. However, estrogen treatment did not increase the proportion of small, dense LDL III particles or result in conversion to LDL pattern B, attributes of LDL that have been associated with increased coronary artery disease risk in men." @default.
- W2018482638 created "2016-06-24" @default.
- W2018482638 creator A5021876776 @default.
- W2018482638 creator A5068254500 @default.
- W2018482638 creator A5074148505 @default.
- W2018482638 creator A5074249857 @default.
- W2018482638 creator A5082424413 @default.
- W2018482638 creator A5089359619 @default.
- W2018482638 date "1993-09-01" @default.
- W2018482638 modified "2023-10-18" @default.
- W2018482638 title "Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women" @default.
- W2018482638 cites W1486434785 @default.
- W2018482638 cites W17105541 @default.
- W2018482638 cites W1979068480 @default.
- W2018482638 cites W1986287368 @default.
- W2018482638 cites W1986696054 @default.
- W2018482638 cites W1987144846 @default.
- W2018482638 cites W1997141513 @default.
- W2018482638 cites W2000934511 @default.
- W2018482638 cites W2006818541 @default.
- W2018482638 cites W2007197636 @default.
- W2018482638 cites W2007233632 @default.
- W2018482638 cites W2034863977 @default.
- W2018482638 cites W2055781203 @default.
- W2018482638 cites W2058386687 @default.
- W2018482638 cites W2060539696 @default.
- W2018482638 cites W2063293597 @default.
- W2018482638 cites W2082803118 @default.
- W2018482638 cites W2085036062 @default.
- W2018482638 cites W2085355343 @default.
- W2018482638 cites W2089286420 @default.
- W2018482638 cites W2094794822 @default.
- W2018482638 cites W2101320446 @default.
- W2018482638 cites W2109947055 @default.
- W2018482638 cites W2109984615 @default.
- W2018482638 cites W2119834982 @default.
- W2018482638 cites W2120955256 @default.
- W2018482638 cites W2161721693 @default.
- W2018482638 cites W2162462798 @default.
- W2018482638 cites W2163437618 @default.
- W2018482638 cites W2169238131 @default.
- W2018482638 cites W2251704643 @default.
- W2018482638 cites W2972867833 @default.
- W2018482638 cites W3022017015 @default.
- W2018482638 cites W4232115780 @default.
- W2018482638 cites W4236503450 @default.
- W2018482638 cites W4240640698 @default.
- W2018482638 cites W4254869113 @default.
- W2018482638 cites W4376522634 @default.
- W2018482638 doi "https://doi.org/10.1016/0026-0495(93)90273-q" @default.
- W2018482638 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8412768" @default.
- W2018482638 hasPublicationYear "1993" @default.
- W2018482638 type Work @default.
- W2018482638 sameAs 2018482638 @default.
- W2018482638 citedByCount "78" @default.
- W2018482638 countsByYear W20184826382015 @default.
- W2018482638 crossrefType "journal-article" @default.
- W2018482638 hasAuthorship W2018482638A5021876776 @default.
- W2018482638 hasAuthorship W2018482638A5068254500 @default.
- W2018482638 hasAuthorship W2018482638A5074148505 @default.
- W2018482638 hasAuthorship W2018482638A5074249857 @default.
- W2018482638 hasAuthorship W2018482638A5082424413 @default.
- W2018482638 hasAuthorship W2018482638A5089359619 @default.
- W2018482638 hasConcept C126322002 @default.
- W2018482638 hasConcept C134018914 @default.
- W2018482638 hasConcept C142724271 @default.
- W2018482638 hasConcept C159654299 @default.
- W2018482638 hasConcept C185592680 @default.
- W2018482638 hasConcept C203014093 @default.
- W2018482638 hasConcept C204787440 @default.
- W2018482638 hasConcept C27081682 @default.
- W2018482638 hasConcept C2776194381 @default.
- W2018482638 hasConcept C2777164284 @default.
- W2018482638 hasConcept C2778163477 @default.
- W2018482638 hasConcept C2778913445 @default.
- W2018482638 hasConcept C2779620165 @default.
- W2018482638 hasConcept C2780072125 @default.
- W2018482638 hasConcept C62746215 @default.
- W2018482638 hasConcept C71924100 @default.
- W2018482638 hasConcept C8243546 @default.
- W2018482638 hasConceptScore W2018482638C126322002 @default.
- W2018482638 hasConceptScore W2018482638C134018914 @default.
- W2018482638 hasConceptScore W2018482638C142724271 @default.
- W2018482638 hasConceptScore W2018482638C159654299 @default.
- W2018482638 hasConceptScore W2018482638C185592680 @default.
- W2018482638 hasConceptScore W2018482638C203014093 @default.
- W2018482638 hasConceptScore W2018482638C204787440 @default.
- W2018482638 hasConceptScore W2018482638C27081682 @default.
- W2018482638 hasConceptScore W2018482638C2776194381 @default.
- W2018482638 hasConceptScore W2018482638C2777164284 @default.
- W2018482638 hasConceptScore W2018482638C2778163477 @default.
- W2018482638 hasConceptScore W2018482638C2778913445 @default.
- W2018482638 hasConceptScore W2018482638C2779620165 @default.
- W2018482638 hasConceptScore W2018482638C2780072125 @default.
- W2018482638 hasConceptScore W2018482638C62746215 @default.
- W2018482638 hasConceptScore W2018482638C71924100 @default.
- W2018482638 hasConceptScore W2018482638C8243546 @default.
- W2018482638 hasIssue "9" @default.